Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes

Clinical trial NCT05718544 · COMPLETED

Trial details

NCT number: NCT05718544
Sponsor: Peking University First Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Scoliosis Correction Postoperative Analgesia Esketamine Dexmedetomidine Chronic Postsurgical Pain

Start date: 2023-01-30
Primary completion: 2023-09-07
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.